Regulatory, Translational, and Operational Considerations for the Incorporation of Biomarkers in Drug Development.

Hatcher H, Stankeviciute S, Learn C, Qu AX

Open source

DOI
10.1007/s43441-025-00763-5
Published
2025 May
Container
Therapeutic innovation & regulatory science
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s43441-025-00763-5,
  title = {Regulatory, Translational, and Operational Considerations for the Incorporation of Biomarkers in Drug Development.},
  author = {Hatcher H and Stankeviciute S and Learn C and Qu AX},
  year = {2025},
  journal = {Therapeutic innovation \& regulatory science},
  doi = {10.1007/s43441-025-00763-5},
  url = {https://doi.org/10.1007/s43441-025-00763-5}
}

RIS

TY  - JOUR
TI  - Regulatory, Translational, and Operational Considerations for the Incorporation of Biomarkers in Drug Development.
AU  - Hatcher H
AU  - Stankeviciute S
AU  - Learn C
AU  - Qu AX
PY  - 2025
JO  - Therapeutic innovation & regulatory science
DO  - 10.1007/s43441-025-00763-5
UR  - https://doi.org/10.1007/s43441-025-00763-5
ER  - 

APA

H, H., S, S., C, L., & AX, Q. (2025). Regulatory, Translational, and Operational Considerations for the Incorporation of Biomarkers in Drug Development.. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-025-00763-5

Source records